home.aspx
 
EVENTS

Update CME - Internal Medicine & Primary Care
UPDATE CME - INTERNAL MEDICINE & PRIMARY CARE
October 29-01, 2020
Earn 30 CME Credits by attending our Update CME Internal Medicine and Primary Care Conference either in person or via live stream!Expert speakers from The University of Chicago, Johns Hopkins, and University of California, Los Angeles will be presenting on the latest clinical guidelines. We offer in...

Internal Medicine for Primary Care
INTERNAL MEDICINE FOR PRIMARY CARE
October 30-01, 2020
The Internal Medicine for Primary Care conference will cover areas like Internal Medicine for Primary Care Physicians, Issues in Women's Health Cardio, Pulmonary for Primary Care Physicians, Neurology for the Non-Neurologist.

Cancer IQ, Inc.

SHARESHARESHARE
CancerIQ helps providers use genetic information to predict, pre-empt, and prevent disease - starting with cancer. By making is easier to identify patients at risk, offer a genetic evaluation at point of care, and design a tailored cancer prevention plan - we can help healthcare systems get ahead of this costly and emotionally devastating disease.
SHARESHARESHARE

RELATED NEWS


Cancer Prevention Pharmaceuticals, Inc. (CPP), a private biotech company developing novel therapeutics to prevent cancer and other diseases, announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking accelerated approval for CPP-1X/sul for treatment of adults with familial adenomatous polyposis (FAP).

FAP is a rare genetic disease that if left untreated progresses to colorectal cancer in nearly 100% of patients. The clinical...

BUSINESS WIRE
READ MORE

Cancer Research UK has announced that incidences of melanoma have increased by 45% since 2004. Latest figures show that rates have increased by more than a third 35% for women and by almost three-fifths 55% for men, and that rates for 25-49 year-olds have increased by as much as 70% since the 1990s. Despite these rising figures, melanoma is still most prevalent in those over 65. The figures have been released to mark the launch of the charity’s Own Your Tone campaign which encourages peopl...

READ MORE

A study published by The BMJ has reported a possible association between higher consumption of sugary drinks and and an increased risk of cancer. The data comes from a team of researchers based in France, who set out to assess the associations between the consumption of sugary drinks (sugar sweetened beverages and 100% fruit juices), artificially sweetened beverages, and risk of overall cancer, as well as breast, prostate, and bowel cancers. The results show that a 100 ml per day increase in the...

READ MORE

The largest ever study of advanced prostate cancer genomics has revealed that men with mutations in the retinoblastoma gene in their tumours were more than three times as likely to die and nearly seven times as likely to relapse on standard treatments as those without the gene. Scientists identified the gene mutation in the tumours of men, which could help to pick out patients for more intensive treatment in the future. The gene in question – the retinoblastoma gene – is known as RB1...

READ MORE

Bristol-Myers Squibb’s immunotherapy Opdivo (nivolumab) will not be available to advanced bladder cancer patients for at least three years in much of the UK after NICE published final guidance that rejected the drug for regular NHS funding in this use. Following its usual review process, NICE concluded in final guidance that Opdivo is not cost-effective for treating local advanced unresectable or metastatic urothelial cancer, after platinum-based chemotherapy....
PHARMAPHORUM
READ MORE

Roche is hoping its Tecentriq will be the first immunotherapy approved in tough-to-treat breast cancer after it stayed the spread of “triple negative” disease in a phase 3 trial. When combined with Celgene’s chemotherapy Abraxane (nab-paclitaxel) Tecentriq produced a statistically significant improvement in progression-free survival compared with chemotherapy, in PD-L1 positive first-line metastatic triple negative breast cancer (TNBC) patients. An interim analysis showed an en...
PHARMAPHORUM MEDIA LIMITED
READ MORE

As the opioid epidemic continues to be a grave concern for many across the world some scientists in Israel have been looking at the efficacy of medical cannabis for cancer pain; significant findings included a reduction or elimination (in some cases) of opioid use.  The study, published in the European Journal of Internal Medicine, is one of the largest in size because of the differences in medical marijuana laws in Israel.  The medical marijuana program is supported by government and ...
LABROOTS
READ MORE

Apexian Pharmaceuticals is pleased to announce that the National Cancer Institute (NCI) has selected the company to participate in its highly competitive Small Business Innovation Research (SBIR) Investor Initiatives program, that encourages domestic small businesses to engage in Research and Development (R&D) that has the potential for commercialization....

READ MORE

It is looking unlikely that patients in England and Wales with advanced renal cell carcinoma will be getting routine NHS access to Eisai’s Kisplyx or Eusa Pharma’s Fotivda, after cost regulators issued draft guidelines turning down their use. The National Institute for Health and Care Excellence said it is not recommending NHS funding for Kisplyx (lenvatinib) in combination with everolimus for previously treated patients because of uncertainties in the clinical evidence. While trial data suggest...

READ MORE

Pancreatic cancer is now the third leading cause of cancer mortality. Its incidence is increasing in parallel with the population increase in obesity, and its five-year survival rate still hovers at just 8 to 9 percent. Research led by Nada Kalaany, PhD, at Boston Children's Hospital and the Broad Institute of MIT and Harvard, now suggests a novel approach to treating this deadly cancer: targeting an enzyme that tumors use to get rid of nitrogen. The study, published online in Nature Communicati...

READ MORE

EVENTS

Internal Medicine for Primary Care
INTERNAL MEDICINE FOR PRIMARY CARE
October 30-01, 2020
The Internal Medicine for Primary Care conference will cover areas like Internal Medicine for Primary Care Physicians, Issues in Women's Health Cardio, Pulmonary for Primary Care Physicians, Neurology for the Non-Neurologist.

Symposium on Advanced Wound Care Fall
SYMPOSIUM ON ADVANCED WOUND CARE FALL
October 30-01, 2020
The Symposium on Advanced Wound Care Fall meeting (SAWC Fall) serves as a forum to connect the entire wound care team — physicians, nurses, physical therapists, researchers, scientists, podiatrists, and dietitians — with the foremost experts in wound care to improve patient outcomes thro...